Dr Deonarain is attending and presenting a lecture titled "Development of Next-Generation Antibody Fragment Drug Conjugates Tailored for Gastric Cancer" at the 6th Annual Next-Generation Immuno-oncology Conference, 10-11 March, 2022, London.
Antikor Biopharma Ltd is a private multidisciplinary biopharmaceutical company spun out from Imperial College London. The company is located at the Stevenage Bioscience Catalyst on the GSK site close to the life science clusters of Cambridge and London. The company is leveraging technologies acquired from Photobiotics (now a subsidiary company) in the development of more effective Antibody-Drug Conjugates in the treatment of numerous cancers and in other therapeutic areas.